Therapeutic management in patients with renal failure who experience an acute coronary syndrome

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 1, 2010, Pages 87-94

  Cardinal, Héloise ^a,b   Bogaty, Peter ^c   Madore, Francois ^d   Boyer, Luce ^c   Joseph, Lawrence ^b   Brophy, James M ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; WARFARIN;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULATION; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HEMODYNAMICS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE;

ACUTE CORONARY SYNDROME; AGED; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; KIDNEY FAILURE; MALE; PROSPECTIVE STUDIES;

EID: 75749146665     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04290609     Document Type: Article

References (36)

1. Collins AJ, Li S, Ma JZ, Herzog C: Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis: 38[Suppl 1]: S26-S29, 2001
2. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58: 353-362, 2000
3. Xue JL, Frazier ET, Herzog CA, Collins AJ: Association of heart disease with diabetes and hypertension in patients with ESRD. Am J Kidney Dis 45: 316-323, 2005
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
5. Bonello L, De Labriolle A, Roy P, Steinberg DH, Okabe T, Pinto Slottow TL, Xue Z, Torguson R, Suddath WO, Satler LF, Kent KM, Pichard AD, Lindsay J, Waksman R: Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. Am J Cardiol 102: 535-540, 2008
6. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295, 2004
7. Han JH, Chandra A, Mulgund J, Roe MT, Peterson ED, Szczech LA, Patel U, Ohman EM, Lindsell CJ, Gibler WB: Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. Am J Med 119: 248-254, 2006
8. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137: 555-562, 2002
9. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS: Acute myocardial infarction and renal dysfunction: a high risk combination. Ann Intern Med 137: 563-570, 2002
10. Chertow GM, Normand SL, McNeil BJ: "Renalism": Inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol 15: 2462-2468, 2004
11. Keough-Ryan TM, Kiberd BA, Dipchand CS, Cox JL, Rose CL, Thompson KJ, Clase CM: Outcomes of acute coronary syndrome in a large Canadian cohort: Impact of chronic renal insufficiency, cardiac interventions, and anemia. Am J Kidney Dis 46: 845-855, 2005
12. Mehta RH, Roe MT, Chen AY, Lytle BL, Pollack CV Jr., Brindis RG, Smith SC, Jr., Harrington RA, Fintel D, Fraulo ES, Califf RM, Gibler WB, Ohman EM, Peterson ED: Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: Insights from the CRUSADE initiative. Arch Intern Med 166: 2027-2034, 2006
13. Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, DeYoung P, Fitchett DH, Langer A, Goodman SG: Optimal medical therapy at discharge in patients with acute coronary syndromes: Temporal changes, characteristics, and 1-year outcome. Am Heart J 154: 1108-1115, 2007
14. Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Bertrand F, Dagenais GR, Brophy JM: Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (Recurrence and Inflammation in the Acute Coronary Syndromes) study. J Am Coll Cardiol 52: 2339-2346, 2008
15. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 29: 31-41, 1976
16. Melloni C, Peterson ED, Chen AY, Szczech LA, Newby LK, Harrington RA, Gibler WB, Ohman EM, Spinler SA, Roe MT, Alexander KP: Cockcroft-Gault versus modification of diet in renal disease: Importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 51: 991-996, 2008
17. Redelmeier DA, Tan SH, Booth GL: The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 338: 1516-1520, 1998
18. McCullough PA, Nowak RM, Foreback C, Tokarski G, Tomlanovich MC, Khoury N, Weaver WD, Sandberg KR, McCord J: Emergency evaluation of chest pain in patients with advanced kidney disease. Arch Intern Med 162: 2464-2468, 2002
19. Brophy DF, Martin EJ, Carr SL, Kirschbaum B, Carr ME Jr: The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients. Thromb Res 119: 723-729, 2007
20. Winkelmayer WC, Levin R, Setoguchi S: Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol 3: 1415-1422, 2008
21. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Garg M, McCullough PA: Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37: 1191-1200, 2001
22. Barrett BJ, Parfrey PS: Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 354: 379-386, 2006
23. Roghi A, Savonitto S, Cavallini C, Arraiz G, Angoli L, Castriota F, Bernardi G, Sansa M, De Servi S, Pitscheider W, Danzi GB, Reimers B, Klugmann S, Zaninotto M, Ardissino D: Impact of acute renal failure following percutaneous coronary intervention on long-term mortality. J Cardiovasc Med (Hagerstown) 9: 375-381, 2008
24. Harada RK, Eagle KA, Kline-Rogers EM, Fang J, Smith D, Mukherjee D: Low utilization of secondary preventive medications and its potential impact in patients with chronic kidney disease and acute coronary syndromes. Indian Heart J 58: 222-229, 2006
25. Tamargo J, Delpon E: Optimization of beta-blockers' pharmacology. J Cardiovasc Pharmacol 16[Suppl 5]: S10-S18, 1990
26. Barakat K, Wilkinson P, Deaner A, Fluck D, Ranjadayalan K, Timmis A: How should age affect management of acute myocardial infarction? A prospective cohort study. Lancet 353: 955-959, 1999
27. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA: National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 280: 623-629, 1998
28. Chan DT, Irish AB, Dogra GK, Watts GF: Dyslipidaemia and cardiorenal disease: Mechanisms, therapeutic opportunities and clinical trials. Atherosclerosis 196: 823-834, 2008
29. Davidson MH, Armani A, McKenney JM, Jacobson TA: Safety considerations with fibrate therapy. Am J Cardiol 99: 3C-18C, 2007
30. Karie S L-VV, Deray G, Isnard-Bagnis C: Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant. Presse Med 35: 219-229, 2006
31. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238-248, 2005
32. Pritchard S: Impact of dyslipidemia in end-stage renal disease. J Am Soc Nephrol 14[Suppl 4]: S315-S320, 2003
33. Bolego C, Baetta R, Bellosta S, Corsini A, Paoletti R: Safety considerations for statins. Curr Opin Lipidol 13: 637-644, 2002
34. Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK: Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: The TNT (Treating to New Targets) study. J Am Coll Cardiol 51: 1448-1454, 2008
35. Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M: Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 110: 1557-1563, 2004
36. McPherson R, Frohlich J, Fodor G, Genest J, Canadian Cardiovascular S: Canadian Cardiovascular Society position statement - Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 22: 913-927, 2006